Clinical Rheumatology

, Volume 6, Supplement 1, pp 9–17 | Cite as

Systemic diseases and the detection of antinuclear and anticytoplasmic antibodies. An hystorical review

  • M. Walravens
General Lecture

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Osler, W. On the visceral complications of erythema exudativum multiformae. Am J Med Sci, 1895, 110, 629.Google Scholar
  2. 2.
    Lipman, E., Sacks, B. A hitherto undescribed form of vascular and mural endocarditis. Trans Assoc Am Phys, 1923, 38, 46.Google Scholar
  3. 3.
    Rose, E., Pillsbury, D.M. Acute disseminated lupus erythematosus — a systemic disease. Ann Intern Med, 1939, 12, 951.Google Scholar
  4. 4.
    Hargraves, M.M., Richmond, H., Morton, R. Presentation of two bone marrow elements: the ‘tart’ cell and the ‘LE’ cell. Proceedings of the Mayo Clinic, 1948, 23, 25–28.Google Scholar
  5. 5.
    Harvey, A.M., Shulman, L.E., Tumulty, P.A. et al. Systemic lupus erythematosus. Review of the literature and clinical analysis of 138 cases. Baltimore, The Williams & Wilkins Company, 1955.Google Scholar
  6. 6.
    Fries, J.F., Holman, H.R. Recent evolution of systemic lupus erythematosus. In: Systemic lupus erythematosus. A clinical analysis, Vol. VI Major problems in internal medicine, W.B. Saunders Company, 1975, 2–7.Google Scholar
  7. 7.
    Fries, J.F., Weyl, S., Holman, H.R. Estimating prognosis in systemic lupus erythematosus. Am J Med, 1974, 57, 562.Google Scholar
  8. 8.
    Perry, H.M., Schroeder, H.A. Syndrome simulating collagen disease caused by hydralazine (apresoline). J Am Med Assoc, 1954, 154, 670–673.Google Scholar
  9. 9.
    Dustan, H.P., Taylor, R.D., Corcoran, AC, Page, I.H. Rheumatic and febrile syndrome during prolonged hydralazine therapy. J Am Med Assoc, 1954, 154, 23–39.Google Scholar
  10. 10.
    Ladd, A.T. Procainamide-included lupus erythematosus. N Engl J Med, 1962, 267, 1357–1358.Google Scholar
  11. 11.
    Tan, E.M., Portanova, J.P. The role of histones as auto-antigens in drug-related lupus erythematosus. Arthritis Rheum, 1981, 24, 1064–1069.Google Scholar
  12. 12.
    Rodnan, G.P., Benedek, T.G. An historical account of the study of progressive systemic aclerosis (diffuse scleroderma). Ann Inter Med, 1962, 57, 305–319.Google Scholar
  13. 13.
    Rodnan, G.P., Benedek, T.G. History of scleroderma. Ann Intern Med, 1978, 89, 725.Google Scholar
  14. 14.
    Curzio, C. Discussioni Anatomico-Pratiche di un raro, e stravagante morbo cutaneo in uno giovane Donna felicemente curato in questo grande Ostedale degl'Incruabili. Napoli: Giovanni de Simone, 1753.Google Scholar
  15. 15.
    Goetz, R.H. Pathology of progressive systemic sclerosis (generalised scleroderma) with special reference to changes in the viscera. Clinical Proceedings. J Cape Town Post-Grad Med Assoc, 1945, 4, 337–392.Google Scholar
  16. 16.
    Medsger, T.A. Jr., Masi, A.T. Epidemiology of systemic sclerosis (scleroderma). Ann Inter Med, 1971, 74, 714–721.Google Scholar
  17. 17.
    Kurland, L.T., Hauser, W.A., Ferguson, R.H., Holley, K.E. Epidemiologic features of diffuse connective tissue disorders in Rochester, Minnesota, 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc, 1969, 44, 469–663.Google Scholar
  18. 18.
    Hadden, W.B. On “dry mouth”, or suppression of the salivary and buccal secretions. Trans Clin Soc London, 1888, 21, 176.Google Scholar
  19. 19.
    Houwer, A.W.M. Keratitis filamentosa and chronic arthritis. Tr Ophtal Soc UK, 1927, 47, 88.Google Scholar
  20. 20.
    Sjögren, H. Zur Kenntnis der Keratoconjunctivitis sicca (Keratitis filiformis bei hypofunktion der Tränendrüsen). Acta Ophtal. (Kbh), 1933, 11, 1.Google Scholar
  21. 21.
    Clark, G.M., Reichlin Tomasi M.T.B., Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol, 1969, 102, 117.Google Scholar
  22. 22.
    Matticli, M., Reichlin, M. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigan. Arthritis Rhum 1974, 17, 421.Google Scholar
  23. 23.
    Alspaugh, M.A., Talal, N., Tan E.M., Differentiation and characterization of autoantibodies and their antigens in SjPorgen's syndrome. Arthritis Rheum, 1976, 19, 216.Google Scholar
  24. 24.
    Sharp, G.C., Irvin, W.S., Gould, G.R., Tan, E.M. Specific antibody to the extractable nuclear antigen (ENA) in the mixed connective tissue disease syndrome. Proceedings of the 42nd Annual Meeting. J Lab Clin Med, 1969, 74, 1010–1011.Google Scholar
  25. 25.
    Sharp, G.C. Mixed connective tissue disease. Bull Rheum Dis, 1975, 25, 828–831.Google Scholar
  26. 26.
    Reichlin, M. Problems in differentiating SLE and mixed connective tissue disease. N Eng J Med, 1976, 295, 1194–1195.Google Scholar
  27. 27.
    Robbins, W.C., Homan, H.R., Deicher, H., Kunkel, H.G. Complement fixation with cell nuclei and CNA in lupus erythematosus. Proceedings of the Society for Experimental Biology (New York), 1957, 96, 575.Google Scholar
  28. 28.
    Seligmann, M. Mise en évidence dans le serum de malades atteints de lupus érythémateux disséminé d'une substance determinant une réaction de précipitation avec l'acide désoxyribonucléique. CR Acad Sci, 1957, 245, 243.Google Scholar
  29. 29.
    Miescher, P., Strassle, R., New serological methods for detection of LE factor. Vox Sanguinis, 1957, 2, 283.Google Scholar
  30. 30.
    Cepellini, R., Polli, E., Celeda, F. A DNA reacting factor in serum of a patient with lupus erythematosus diffusus. Prov Soc Exp Biol (NY), 1957, 96, 572.Google Scholar
  31. 31.
    Asherson, G.L., Antibodies against nuclear and cytoplasmic cell constituents in systemic lupus erythematosus and other diseases. Br J Exp Pathol, 1959, 40, 209.Google Scholar
  32. 32.
    Lachmann, P.J., Kunkel, H.G. Correlation of antinuclear antibodies and nuclear staining patterns. Lancet, 1961, 2, 436.Google Scholar
  33. 33.
    Tan, E.M., Kunke, H.G. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol, 1966, 96, 464.Google Scholar
  34. 34.
    Tan, E.M. An immunologic precipitin system between soluble nucleoprotein and serum antibody in systemic lupus erythematosus. J Clin Invest, 1967, 46, 735.Google Scholar
  35. 35.
    Scopelitis, E., Biundo, J.J., Jr., Alspaugh M.A. Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus. Arthritis Rheum, 1980, 23, 287.Google Scholar
  36. 36.
    Tan, E.M., Kunkel, H.G. Characteristics of a soluble nuclear antigen pricipitating with sera of patients with systemic lupus erythematosus. J Immunol, 1966, 96, 464.Google Scholar
  37. 37.
    Fishbein, E., Alarcon-Segovia, D., Vega, J.M. Antibodies to histnes in systemic lupus erythematosus. Clin Exp Immunol, 1979, 36, 145.Google Scholar
  38. 38.
    Northway, J.D., Tan, E.M. Differentiation of antinuclear antibodies giving speckled staining patterne in immunofluorescende. Clin Immunol Immunopathol, 1972, 1, 140.Google Scholar
  39. 39.
    Pillarisetty, R.J., Becker, M.J., Palmer, D.W., Tala, N. Antibodies binding polyriboadenylic acid in systemic lupus erythematosus. Immunochemical characterization and isolation by affinity chromatography. Clin Exp Immunol, 1975, 22, 419.Google Scholar
  40. 40.
    Pillarisetty, R.J., Talal, N. Clinical studies of antibodies binding polyriboadenylic acid in systemic lupus erythematosus. Arthritis Rheum, 1976, 19, 705.Google Scholar
  41. 41.
    Alspaugh, M.A., Tan, E.M. Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Arthritis reactive with a cell-associated antigen. Arthritis Rheum, 1976, 19, 711.Google Scholar
  42. 42.
    Maddison, P.J., Reichlin, M., Provost, T.T. Association of autoantibodies to certain cytoplasmic antigens with systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum, 1977, 20, 126 (Abstract).Google Scholar
  43. 43.
    Provost, T.T., Ahmed, A.R., Maddison, P.J., Reichlin, N. Antibodies to cytoplasmic antigens in lupus erythematosus. Serologic marker for systemic disease. Arthritis Rheum, 1977, 20, 1457.Google Scholar
  44. 44.
    Wolfe, J.F., Adelstein, E., Sharp, G.C. Antinuclear antiboy with distinct specificity for polymyositis. J. Clin Invest, 1977, 59, 176.Google Scholar
  45. 45.
    Miyawaki, S., Kohmoto, K., Kurata, N., Ofuji. Identification and characterization of two new soluble nuclear antigens reactive with sera of patients with connective tissue disease. Arthritis Rheum, 1978, 21, 803.Google Scholar
  46. 46.
    Winn, D.M., Wolfe, J.F., Harmon, D., Sharp G.C. Characterization of a distinct nuclear acidic protein antigen (MA) and clinical findings in sytemic lupus erythematosys patients with MA antibodies. J Clin Invest, 1979, 64, 820.Google Scholar
  47. 47.
    Tan, E.M., Rodnan, G.P., Garcia, I., Moroi, Y., Fritzler, M.J., Peebles, C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Arhtritis Rheum, 1980, 23, 617.Google Scholar
  48. 48.
    Nishikai, A., Reichlin, M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum, 1980, 23, 881.Google Scholar
  49. 49.
    Smeenk, R., Aarden, L. The use of polyethylene glycol precipitation to detect low-avidity anti-DNA antibodies in systemic lupus erythematosus. J Immunol Methods, 1980, 39, 165–180.Google Scholar
  50. 50.
    Smeenk, R., van der Lelij, G., Aarden, L. Avidity of antibodies to dsDNA. Comparison of IFT on Chrithidia Luciliae, FARR assay and PEG assay, J Immunol, 1982, 128, 73–78.Google Scholar
  51. 51.
    Weston, W.L., Franco, H.L., Tan, E. Association of antibodies to sicca syndrome antigens in newborns with lupus erythematosus and their mothers. Clin Res, 1980, 28, 582.Google Scholar
  52. 52.
    Scott, J.S., Maddison, P.J., Taylor, P.V., Esscher, E., Scott, O., Skinner, R.P. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med, 1983, 309(4), 209–212.Google Scholar

Copyright information

© Acta Medica Belgica 1987

Authors and Affiliations

  • M. Walravens
    • 1
  1. 1.Division of Rheumatology and Division of Immunology, Department of Internal MedicineK.U. LeuvenBelgium

Personalised recommendations